Skip to main content
OpenTrials

Clinical trial condition

Mild Alzheimer's Disease

Explore clinical trials studying Mild Alzheimer's Disease. Study availability and eligibility vary by location and protocol.

10 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Mild Alzheimer's Disease trial results

Completed

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS-MAPTRx in Patients With Mild Alzheimer's Disease

NCT03186989

Conditions
Brain Diseases, Central Nervous System Diseases, Dementia, +12 more
Locations
  • Montreal Neurological Hospital Montreal, Canada
  • Clinical Research Services Turku CRST Turku, Finland
  • St Josef Hospital Bochum, Germany
  • Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) Bonn, Germany
View all 13 locations
View Trial Details
Completed

Deferiprone to Delay Dementia (The 3D Study)

NCT03234686

Conditions
Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +11 more
Locations
  • KaRa Institute of Neurological Diseases Macquarie Park, New South Wales, Australia
  • Hunter New England Local Health District Waratah, New South Wales, Australia
  • Box Hill Hospital Box Hill, Victoria, Australia
  • Austin Health Heidelberg, Victoria, Australia
View Trial Details
Completed

Lomecel-B Effects on Alzheimer's Disease

NCT05233774

Conditions
Mild Alzheimer's Disease
Locations
  • Visionary Investigators Network Aventura, Florida, United States
  • Brain Matters Research Delray Beach, Florida, United States
  • Science Connections - Research Partner Group Multispecialty Group Doral, Florida, United States
  • Bruce W. Carter VA Medical Center Miami, Florida, United States
View all 13 locations
View Trial Details
Completed

A Study of the Safety and Tolerability of AZD5213 Effect on Sleep for Patients With Alzheimer's/Cognitive Impairment

NCT01548287

Conditions
Cognition Disorders, Cognitive Dysfunction, Mental Disorders, +3 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Indio, California, United States
  • Research Site Lomita, California, United States
  • Research Site San Francisco, California, United States
View all 13 locations
View Trial Details
Completed

An Escalating Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LNK 754 in Elderly Volunteers and in Subjects With Mild Alzheimer's Disease

NCT01013610

Conditions
Mild Alzheimer's Disease
Locations
  • Dedicated Phase I Phoenix, Arizona, United States
  • Collaborative Neuroscience Network Long Beach, California, United States
  • Elite Research Insitute Miami, Florida, United States
  • Compass Research, LLC Orlando, Florida, United States
View Trial Details

Related conditions